1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

R Stahel; N Thatcher; M Früh; C Le Péchoux; P E Postmus; J B Sorensen; E Felip; Panel members

doi:http://dx.doi.org/10.1093/annonc/mdr313

1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

R Stahel, N Thatcher, M Früh, C Le Péchoux, P E Postmus, J B Sorensen, E Felip, Panel members

42 Citations (Scopus)

Abstract

The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

Original language	English
Journal	Annals of Oncology
Volume	22
Issue number	9
Pages (from-to)	1973-80
Number of pages	8
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdr313
Publication status	Published - Sept 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://dx.doi.org/10.1093/annonc/mdr313

Cite this

@article{39aa59b3847c417c88d938443f2b2431,

title = "1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer",

abstract = "The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.",

author = "R Stahel and N Thatcher and M Fr{\"u}h and {Le P{\'e}choux}, C and Postmus, {P E} and Sorensen, {J B} and E Felip and S{\o}rensen, {Jens Benn}",

year = "2011",

month = sep,

doi = "http://dx.doi.org/10.1093/annonc/mdr313",

language = "English",

volume = "22",

pages = "1973--80",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

AU - Stahel, R

AU - Thatcher, N

AU - Früh, M

AU - Le Péchoux, C

AU - Postmus, P E

AU - Sorensen, J B

AU - Felip, E

AU - Panel members

PY - 2011/9

Y1 - 2011/9

N2 - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

AB - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

U2 - http://dx.doi.org/10.1093/annonc/mdr313

DO - http://dx.doi.org/10.1093/annonc/mdr313

M3 - Journal article

SN - 0923-7534

VL - 22

SP - 1973

EP - 1980

JO - Annals of Oncology

JF - Annals of Oncology

IS - 9

ER -

1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this